Chiron Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Sell |
73,072
-1,963
| -3% | -$47.6K | 1.54% | 16 |
|
|
2025
Q1 | $1.9M | Buy |
75,035
+14,740
| +24% | +$374K | 1.73% | 10 |
|
|
2024
Q4 | $1.6M | Sell |
60,295
-7,975
| -12% | -$212K | 1.51% | 11 |
|
|
2024
Q3 | $1.98M | Sell |
68,270
-1,716
| -2% | -$49.7K | 1.75% | 9 |
|
|
2024
Q2 | $1.96M | Buy |
69,986
+526
| +0.8% | +$14.7K | 1.87% | 8 |
|
|
2024
Q1 | $1.93M | Buy |
69,460
+28,079
| +68% | +$779K | 1.75% | 5 |
|
|
2023
Q4 | $1.19M | Sell |
41,381
-11,448
| -22% | -$330K | 1.04% | 24 |
|
|
2023
Q3 | $1.75M | Buy |
52,829
+32,426
| +159% | +$1.08M | 1.51% | 10 |
|
|
2023
Q2 | $748K | Buy |
20,403
+10,000
| +96% | +$367K | 0.59% | 39 |
|
|
2023
Q1 | $424K | Buy |
10,403
+2,248
| +28% | +$91.7K | 0.3% | 69 |
|
|
2022
Q4 | $418K | Sell |
8,155
-1,100
| -12% | -$56.4K | 0.29% | 65 |
|
|
2022
Q3 | $405K | Buy |
9,255
+1,245
| +16% | +$54.5K | 0.27% | 73 |
|
|
2022
Q2 | $420K | Sell |
8,010
-24,022
| -75% | -$1.26M | 0.27% | 74 |
|
|
2022
Q1 | $1.66M | Sell |
32,032
-26,643
| -45% | -$1.38M | 1.05% | 13 |
|
|
2021
Q4 | $3.47M | Sell |
58,675
-5,896
| -9% | -$348K | 2.5% | 4 |
|
|
2021
Q3 | $2.78M | Sell |
64,571
-69,938
| -52% | -$3.01M | 2.03% | 5 |
|
|
2021
Q2 | $5.27M | Sell |
134,509
-19,320
| -13% | -$757K | 4.39% | 3 |
|
|
2021
Q1 | $5.57M | Buy |
153,829
+90,843
| +144% | +$3.29M | 4.73% | 3 |
|
|
2020
Q4 | $2.32M | Sell |
62,986
-18,305
| -23% | -$674K | 1.91% | 7 |
|
|
2020
Q3 | $2.83M | Buy |
+81,291
| New | +$2.83M | 2.28% | 5 |
|